Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP751972.RADj6zS0CjTe2Nb-5hJ2KnWPLt8GYLnDU_2WSJNinazbU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP751972.RADj6zS0CjTe2Nb-5hJ2KnWPLt8GYLnDU_2WSJNinazbU130_assertion type Assertion NP751972.RADj6zS0CjTe2Nb-5hJ2KnWPLt8GYLnDU_2WSJNinazbU130_head.
- NP751972.RADj6zS0CjTe2Nb-5hJ2KnWPLt8GYLnDU_2WSJNinazbU130_assertion wasGeneratedBy ECO_0000203 NP751972.RADj6zS0CjTe2Nb-5hJ2KnWPLt8GYLnDU_2WSJNinazbU130_provenance.
- NP751972.RADj6zS0CjTe2Nb-5hJ2KnWPLt8GYLnDU_2WSJNinazbU130_assertion wasDerivedFrom befree-20150227 NP751972.RADj6zS0CjTe2Nb-5hJ2KnWPLt8GYLnDU_2WSJNinazbU130_provenance.
- NP751972.RADj6zS0CjTe2Nb-5hJ2KnWPLt8GYLnDU_2WSJNinazbU130_assertion SIO_000772 16793127 NP751972.RADj6zS0CjTe2Nb-5hJ2KnWPLt8GYLnDU_2WSJNinazbU130_provenance.
- NP751972.RADj6zS0CjTe2Nb-5hJ2KnWPLt8GYLnDU_2WSJNinazbU130_assertion evidence source_evidence_literature NP751972.RADj6zS0CjTe2Nb-5hJ2KnWPLt8GYLnDU_2WSJNinazbU130_provenance.
- NP751972.RADj6zS0CjTe2Nb-5hJ2KnWPLt8GYLnDU_2WSJNinazbU130_assertion description "[Low-grade EC that developed in borderline tumors had PTEN and/or K-RAS mutation (4/5, 80%), while high-grade EC had TP53 mutations only.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP751972.RADj6zS0CjTe2Nb-5hJ2KnWPLt8GYLnDU_2WSJNinazbU130_provenance.